Equities

Integrum AB

Integrum AB

Actions
  • Price (SEK)55.40
  • Today's Change0.80 / 1.47%
  • Shares traded3.02k
  • 1 Year change+130.83%
  • Beta1.3857
Data delayed at least 15 minutes, as of May 20 2024 10:12 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Integrum AB is a Sweden-based company within healthcare sector. It provides systems for bone-anchored prostheses for individuals with amputations. The Company’s solutions comprise OPRA Implant System, neural prosthetics, phantom limb pain treatment and prosthetic components. The OPRA implant system is based on osseointegration, enabling the direct connection of an artificial limb to the skeleton. The neural prosthetics technology implies ability to directly connect bionic prostheses to the patient’s bone, nerves, and muscles. A method for limb pain treatment implies motor execution of the phantom limb as a treatment, which is aided by machine learning, augmented and virtual reality. The Company provides a variety of prosthetic components required to connect the OPRA Implant System to external prostheses.

  • Revenue in SEK (TTM)96.19m
  • Net income in SEK8.26m
  • Incorporated1990
  • Employees34.00
  • Location
    Integrum ABKrokslatts Fabriker 50MOELNDAL 431 37SwedenSWE
  • Phone+46 317601060
  • Fax+46 31155260
  • Websitehttps://integrum.se/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Modulight Oyj-1.16tn-1.16tn528.17m70.00--0.8421----------1.26-----------8.39---9.10--114.69---56.816.11--0.1004---12.48-8.20-38.69--63.60--
Bioretec Oy45.51m-44.13m630.11m37.00--6.31--13.85-0.1984-0.19840.20470.42130.55241.463.68105,594.60-53.58-67.11-65.75-97.6069.8570.97-96.98-134.054.86-4.020.0754--32.7719.77-56.82------
Senzime AB (publ)40.59m-131.28m671.79m52.00--2.27--16.55-1.30-1.300.39022.950.10451.345.80---33.80-35.69-35.58-38.0026.75-20.59-323.45-558.685.85--0.0308--154.7761.90-1.09---3.69--
Paxman AB (publ)210.12m8.33m760.50m91.0091.796.2028.233.620.43580.435811.036.451.232.707.672,308,978.004.89-5.086.65-7.7669.6869.383.96-5.071.672.710.1251--43.9929.35180.69--6.26--
Mentice AB254.07m-25.98m815.65m128.00--6.011,989.383.21-1.01-1.0110.035.300.84351.973.882,082,557.00-8.62-7.69-17.02-13.0787.5783.67-10.22-10.000.8586--0.0553--25.5411.7490.81---10.83--
OssDsign AB112.16m-130.49m867.21m----3.69--7.73-1.74-1.741.522.410.34086.546.19---39.65-38.80-44.90-44.7274.5872.29-116.35-203.054.15-30.390.0132--96.8253.26-31.30---60.35--
Integrum AB96.19m8.26m971.62m34.00122.146.8393.7110.100.4470.4475.197.990.59180.58593.83--5.08-6.655.65-7.9586.8081.528.58-11.193.04-4.280.0462--33.2937.39-117.50--86.42--
Optomed Oyj174.13m-50.94m1.18bn114.00--5.19--6.80-0.2575-0.25750.88721.080.51991.703.94131,131.60-15.21-12.95-18.59-15.9066.7665.69-29.25-27.841.72-12.960.1894--3.003.4718.84--7.26--
C Rad AB424.62m35.43m1.31bn87.0037.954.9629.413.091.051.0512.578.031.144.423.824,880,632.009.605.0913.757.0245.8343.128.414.862.27139.130.00640.0040.9217.44375.0510.8933.69--
Data as of May 20 2024. Currency figures normalised to Integrum AB's reporting currency: Swedish Krona SEK

Institutional shareholders

17.17%Per cent of shares held by top holders
HolderShares% Held
Fiducian Investment Management Services Ltd.as of 30 Dec 2022732.77k4.12%
Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 28 Apr 2023717.49k4.03%
Swedbank Robur Fonder ABas of 29 Feb 2024450.00k2.53%
Stena Finance ABas of 30 Dec 2022450.00k2.53%
Didner & Gerge Fonder ABas of 30 Dec 2022400.00k2.25%
Mandarine Gestion SAas of 29 Feb 2024237.50k1.34%
E. �hman J :or Fonder ABas of 29 Feb 202443.95k0.25%
Axxion SA (Luxembourg)as of 30 Jun 202124.01k0.14%
AXA Investment Managers (Paris) SAas of 31 Oct 20230.000.00%
More ▼
Data from 31 Dec 2022 - 30 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.